Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)

SPECIAL INVESTIGATION OF PREGABALIN FOR FIBROMYALGIA

To collect the efficacy and safety information of Pregabalin on Fibromyalgia patients related to their appropriate use in daily practice.

All the patients whom an investigator prescribes the first pregabalin should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.

Inclusion Criteria:

• Clinical diagnosis of Fibromyalgia
• Pregabalin naive patient

Exclusion Criteria:

• Clinical diagnosis of neuropathic pain